FI762810A - - Google Patents

Info

Publication number
FI762810A
FI762810A FI762810A FI762810A FI762810A FI 762810 A FI762810 A FI 762810A FI 762810 A FI762810 A FI 762810A FI 762810 A FI762810 A FI 762810A FI 762810 A FI762810 A FI 762810A
Authority
FI
Finland
Application number
FI762810A
Other languages
Finnish (fi)
Other versions
FI63220C (fi
FI63220B (fi
Inventor
Louis Lafon
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of FI762810A publication Critical patent/FI762810A/fi
Application granted granted Critical
Publication of FI63220B publication Critical patent/FI63220B/fi
Publication of FI63220C publication Critical patent/FI63220C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electronic Switches (AREA)
FI762810A 1975-10-02 1976-10-01 Foerfarande foer framstaellning av nya benshydrylsulfinyler me terapeutisk verkan pao det centrala nervsystemet FI63220C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4041975 1975-10-02
GB40419/75A GB1520812A (en) 1975-10-02 1975-10-02 Benzhydrylsulphinyl derivatives

Publications (3)

Publication Number Publication Date
FI762810A true FI762810A (da) 1977-04-03
FI63220B FI63220B (fi) 1983-01-31
FI63220C FI63220C (fi) 1983-05-10

Family

ID=10414819

Family Applications (1)

Application Number Title Priority Date Filing Date
FI762810A FI63220C (fi) 1975-10-02 1976-10-01 Foerfarande foer framstaellning av nya benshydrylsulfinyler me terapeutisk verkan pao det centrala nervsystemet

Country Status (29)

Country Link
US (1) US4066686A (da)
JP (1) JPS6045186B2 (da)
AT (1) AT347426B (da)
AU (1) AU511619B2 (da)
BE (1) BE846880A (da)
CH (1) CH614934A5 (da)
CS (1) CS200195B2 (da)
DE (1) DE2642511C2 (da)
DK (1) DK151009C (da)
ES (1) ES452063A1 (da)
FI (1) FI63220C (da)
FR (1) FR2326181A1 (da)
GB (1) GB1520812A (da)
GE (1) GEP19960242B (da)
HU (1) HU175109B (da)
IE (1) IE43553B1 (da)
IL (1) IL50599A (da)
LU (1) LU75909A1 (da)
NL (1) NL187629C (da)
NO (1) NO143219C (da)
NZ (1) NZ182207A (da)
OA (1) OA05444A (da)
PH (1) PH12533A (da)
PL (1) PL105506B1 (da)
PT (1) PT65648B (da)
SE (1) SE431088B (da)
SU (1) SU651693A3 (da)
YU (1) YU40464B (da)
ZA (1) ZA765830B (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1106403A (en) * 1977-04-29 1981-08-04 Victor Lafon Process for preparing (3,4-dichlorophenyl-sulphinyl)- acetamidoxime and its addition salts
FR2528041A1 (fr) * 1982-06-04 1983-12-09 Lafon Labor Acides halogenobenzhydrylsulfinylacetohydroxamiques, procede de preparation et utilisation en therapeutique
FR2528040A1 (fr) * 1982-06-04 1983-12-09 Lafon Labor Benzhydrylsulfinylethylamines, procede de preparation et utilisation en therapeutique
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds
FR2561646B1 (fr) * 1984-03-23 1987-10-09 Lafon Labor Derives d'acide (a-(alkylaminomethyl)-benzyl)-thioacetique, procede de preparation et utilisation en therapeutique
FR2569186B1 (fr) * 1984-08-20 1986-09-05 Lafon Labor Derives de 1-(n-(a-amino-a-methylacetyl)-aminophenyl)-2-amino-propanone, procede de preparation et utilisation en therapeutique
DE3604050A1 (de) * 1986-02-08 1987-08-13 Boehringer Mannheim Gmbh Thioether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
FR2606015B1 (fr) * 1986-08-13 1989-05-19 Lafon Labor Derives du benzhydrylthiomethane, leurs procedes de preparation et leurs applications en therapeutique
JPH02162176A (ja) * 1988-12-14 1990-06-21 Sanyo Electric Co Ltd ライトの取付装置
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2708201B1 (fr) * 1993-06-30 1995-10-20 Lafon Labor Utilisation de dérivés d'acétamide pour la fabrication de médicaments.
US5571825A (en) * 1995-03-31 1996-11-05 Warner-Lambert Company Method of selectively inhibiting prostaglandin G/H synthase-2
US6172057B1 (en) 1997-02-27 2001-01-09 American Cyanamid Company N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
DE69823019T2 (de) * 1997-02-27 2005-03-31 Wyeth Holdings Corp. N-hydroxy-2-(alkyl, aryl oder heteroaryl sulfanyl, sulfinyl oder sulfonyl)-3-substituierte alkyl-, aryl- oder heteroarylamide als matrixmetalloproteinaseinhibitoren
US6492396B2 (en) * 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
US6670358B2 (en) * 2000-05-16 2003-12-30 Cephalon, Inc. Substituted thioacetamides
US6875893B2 (en) * 2002-05-23 2005-04-05 Cephalon, Inc. Preparations of a sulfinyl acetamide
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
EP1437345A1 (en) * 2003-01-13 2004-07-14 Organisation de Synthese Mondiale Orsymonde Novel method for preparing methyl 2-diphenylmethylsulfinylacetate
US7186860B2 (en) 2003-01-31 2007-03-06 Alembic Limited Process for the preparation of 2-[(diphenylmethyl) thio] acetamide
JP2006518754A (ja) * 2003-02-24 2006-08-17 マリンクロッド・インコーポレイテッド ベンズヒドリルチオアセトアミドの改良製法
ITMI20031298A1 (it) * 2003-06-26 2004-12-27 Erregierre Spa Processo di preparazione di modafinil forma polimorfa(i).
WO2005046854A2 (en) * 2003-09-12 2005-05-26 Sun Pharmaceutical Industries Limited A process for the preparation of diphenylmethylsulfinyl derivatives
EP1586560A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
EP2043623A4 (en) * 2006-07-12 2013-03-20 Elan Pharma Int Ltd NANOPARTICLE FORMULATIONS OF MODAFINIL
CN101641090B (zh) * 2006-12-19 2012-12-05 亚勒斯有限公司 莫达非尼在制备治疗多动腿综合征的药物中的应用
USD681056S1 (en) * 2012-09-09 2013-04-30 Apple Inc. Electronic device
WO2014138518A2 (en) 2013-03-08 2014-09-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
CN104610108B (zh) * 2015-01-27 2016-03-30 潍坊医学院 一种中枢神经系统药物阿屈非尼中间体化合物的合成方法
US11365195B2 (en) 2017-11-13 2022-06-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Atypical inhibitors of monoamine transporters; method of making; and use thereof
KR102126389B1 (ko) 2018-09-14 2020-06-25 셀라이온바이오메드 주식회사 벤즈히드릴티오 아세트아미드 화합물을 유효성분으로 포함하는 간 질환의 예방 또는 치료용 조성물
KR102277739B1 (ko) 2019-12-11 2021-07-15 셀라이온바이오메드 주식회사 벤즈히드릴 티오 아세트아미드 화합물을 유효성분으로 포함하는 섬유화 질환의 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2394597A (en) * 1942-07-09 1946-02-12 Eastman Kodak Co Preparation of organic dhsocyanates
NL6406688A (da) * 1964-06-05 1965-12-06

Also Published As

Publication number Publication date
NO143219C (no) 1981-01-07
GEP19960242B (en) 1996-06-01
JPS5246058A (en) 1977-04-12
CS200195B2 (cs) 1980-08-29
DE2642511C2 (de) 1986-07-31
IE43553L (en) 1977-04-02
OA05444A (fr) 1981-03-31
FI63220C (fi) 1983-05-10
PH12533A (en) 1979-05-17
ATA720876A (de) 1978-05-15
JPS6045186B2 (ja) 1985-10-08
PT65648A (pt) 1976-10-01
HU175109B (hu) 1980-05-28
DE2642511A1 (de) 1977-04-14
NL187629C (nl) 1991-12-02
FI63220B (fi) 1983-01-31
NL187629B (nl) 1991-07-01
IL50599A0 (en) 1976-12-31
AU1818876A (en) 1978-04-06
YU40464B (en) 1986-02-28
US4066686A (en) 1978-01-03
FR2326181B1 (da) 1980-08-08
NO143219B (no) 1980-09-22
IL50599A (en) 1980-09-16
NO763372L (da) 1977-04-05
SU651693A3 (ru) 1979-03-05
DK437576A (da) 1977-04-03
CH614934A5 (da) 1979-12-28
LU75909A1 (da) 1977-05-11
FR2326181A1 (fr) 1977-04-29
PL105506B1 (pl) 1979-10-31
DK151009B (da) 1987-10-12
ES452063A1 (es) 1977-10-01
AU511619B2 (en) 1980-08-28
ZA765830B (en) 1977-09-28
YU241476A (en) 1982-02-28
AT347426B (de) 1978-12-27
NZ182207A (en) 1978-03-06
PT65648B (fr) 1978-04-07
DK151009C (da) 1988-02-29
SE7610940L (sv) 1977-04-03
IE43553B1 (en) 1981-03-25
BE846880A (fr) 1977-04-01
GB1520812A (en) 1978-08-09
NL7610929A (nl) 1977-04-05
SE431088B (sv) 1984-01-16

Similar Documents

Publication Publication Date Title
FR2326181B1 (da)
FR2316383B1 (da)
FR2303354B1 (da)
FR2336663B1 (da)
JPS523207U (da)
FR2334489B1 (da)
FR2319464B3 (da)
FR2324403B1 (da)
JPS5277104U (da)
JPS51109757U (da)
JPS51102059U (da)
JPS5426205Y2 (da)
JPS553223B2 (da)
JPS51153370U (da)
JPS5282808U (da)
JPS5260237U (da)
JPS51131803U (da)
JPS5196188U (da)
JPS5221777U (da)
CH608311A5 (da)
CH601205A5 (da)
CH602094A5 (da)
CH607471A5 (da)
CH607064A5 (da)
CH606876A5 (da)

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: LABORATOIRE L. LAFON